HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Shimizu Selected Research

Makoto Shimizu Research Topics

Disease

15Inflammation (Inflammations)
08/2021 - 07/2002
10Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2009
8Obesity
01/2021 - 03/2004
5Atherosclerosis
01/2016 - 07/2003
3Stroke (Strokes)
01/2023 - 08/2017
3Heart Failure
01/2023 - 01/2011
3Hemorrhage
01/2023 - 01/2009
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2021 - 05/2008
3Body Weight (Weight, Body)
01/2021 - 07/2009
3Hypersensitivity (Allergy)
06/2020 - 11/2009
3Myocardial Infarction
10/2018 - 01/2012
3Coronary Artery Disease (Coronary Atherosclerosis)
10/2018 - 01/2011
2Atrial Fibrillation
01/2023 - 06/2019
2Hypertrophy
10/2021 - 01/2021
2Hyperglycemia
01/2021 - 08/2006
2Insulin Resistance
01/2021 - 01/2015
2Unstable Angina
10/2018 - 08/2017
2Colitis
02/2015 - 01/2009
2Sleep Initiation and Maintenance Disorders (Insomnia)
07/2014 - 10/2010
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2023
1Cerebral Hemorrhage
01/2023
1Atrophy
11/2022
1Glucose Metabolism Disorders
01/2021
1Muscular Atrophy (Muscle Atrophy)
01/2020
1Infarction (Infarctions)
10/2018
1Diabetes Mellitus
10/2018
1Cerebral Infarction
10/2018
1Hypertension (High Blood Pressure)
04/2018
1Non-alcoholic Fatty Liver Disease
04/2018
1Glucose Intolerance
08/2017
1Intestinal Diseases (Diseases, Intestinal)
02/2017
1Metabolic Diseases (Metabolic Disease)
01/2017
1Anorexia
08/2016
1Weight Gain
08/2016

Drug/Important Bio-Agent (IBA)

6CytokinesIBA
08/2021 - 05/2008
5Interleukin-8 (Interleukin 8)IBA
08/2021 - 08/2005
5Glucose (Dextrose)FDA LinkGeneric
01/2021 - 08/2006
5TaurineFDA Link
01/2019 - 10/2003
5LDL CholesterolIBA
01/2016 - 02/2012
5LipidsIBA
01/2016 - 11/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021 - 08/2005
4CholesterolIBA
01/2020 - 01/2011
4oxidized low density lipoproteinIBA
01/2013 - 07/2003
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2015
3InterleukinsIBA
06/2020 - 05/2008
3Chlorogenic AcidIBA
02/2017 - 02/2015
3LDL Lipoproteins (beta Lipoproteins)IBA
01/2016 - 07/2003
2Messenger RNA (mRNA)IBA
08/2021 - 01/2015
2Blood Glucose (Blood Sugar)IBA
01/2021 - 01/2015
2Interleukin-4 (Interleukin 4)IBA
06/2020 - 11/2009
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
09/2019 - 06/2012
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2018 - 01/2015
2AdiponectinIBA
10/2018 - 01/2015
2CoffeeFDA Link
02/2017 - 05/2008
2LimoninsIBA
01/2017 - 07/2011
2nomilinIBA
01/2017 - 07/2011
2Sterol Regulatory Element Binding ProteinsIBA
08/2015 - 08/2011
2Lipoproteins (Lipoprotein)IBA
01/2015 - 02/2012
2LDL Receptors (LDL Receptor)IBA
01/2015 - 02/2012
2Hypnotics and Sedatives (Sedatives)IBA
07/2014 - 10/2010
2Ezetimibe (Zetia)FDA Link
10/2012 - 01/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2012 - 01/2011
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2011 - 08/2005
2LigandsIBA
02/2009 - 01/2005
1Warfarin (Coumadin)FDA LinkGeneric
01/2023
1AnticoagulantsIBA
01/2023
1CreatineIBA
01/2023
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2022
1maslinic acidIBA
10/2021
1Mechanistic Target of Rapamycin Complex 1IBA
10/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2021
1Chemokine CXCL2IBA
08/2021
1Interleukin-6 (Interleukin 6)IBA
08/2021
1Interleukin-17 (Interleukin 17)IBA
08/2021
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
05/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
05/2021
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
01/2020
1chrysinIBA
09/2019
1Fatty Acids (Saturated Fatty Acids)IBA
09/2019
1RivaroxabanIBA
06/2019
1DabigatranFDA Link
06/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2018
1Pioglitazone (Actos)FDA Link
10/2018
1FructoseIBA
04/2018
1Glycoside Hydrolase InhibitorsIBA
08/2017
1voglibose (Basen)IBA
08/2017
1caffeic acidIBA
02/2017
1NucleotidesIBA
01/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1Amino AcidsFDA Link
01/2017
1Pattern Recognition ReceptorsIBA
01/2017
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2017
1PolyphenolsIBA
01/2017
1IsoflavonesIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1deoxynivalenolIBA
08/2016

Therapy/Procedure

5Therapeutics
01/2023 - 01/2006
2Percutaneous Coronary Intervention
10/2018 - 08/2017
1Secondary Prevention
10/2018
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2017